A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
for Eosinophilic Asthma
20 locations incl. Long Beach
Sponsor: Kymera Therapeutics, Inc.
Sex: All·Age: 18 - 75
Code: NCT07323654·Phase 2·Recruiting